147 related articles for article (PubMed ID: 21523901)
1. Neuroblastoma: a 20-year experience in a UK regional centre.
Salim A; Mullassery D; Pizer B; McDowell HP; Losty PD
Pediatr Blood Cancer; 2011 Dec; 57(7):1254-60. PubMed ID: 21523901
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of stage 3 neuroblastoma.
Modak S; Kushner BH; LaQuaglia MP; Kramer K; Cheung NK
Eur J Cancer; 2009 Jan; 45(1):90-8. PubMed ID: 18996003
[TBL] [Abstract][Full Text] [Related]
3. The impact of surgical radicality on outcome in childhood neuroblastoma.
von Schweinitz D; Hero B; Berthold F
Eur J Pediatr Surg; 2002 Dec; 12(6):402-9. PubMed ID: 12548494
[TBL] [Abstract][Full Text] [Related]
4. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.
Fischer J; Pohl A; Volland R; Hero B; Dübbers M; Cernaianu G; Berthold F; von Schweinitz D; Simon T
BMC Cancer; 2017 Aug; 17(1):520. PubMed ID: 28778185
[TBL] [Abstract][Full Text] [Related]
5. Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study.
Holmes K; Pötschger U; Pearson ADJ; Sarnacki S; Cecchetto G; Gomez-Chacon J; Squire R; Freud E; Bysiek A; Matthyssens LE; Metzelder M; Monclair T; Stenman J; Rygl M; Rasmussen L; Joseph JM; Irtan S; Avanzini S; Godzinski J; Björnland K; Elliott M; Luksch R; Castel V; Ash S; Balwierz W; Laureys G; Ruud E; Papadakis V; Malis J; Owens C; Schroeder H; Beck-Popovic M; Trahair T; Forjaz de Lacerda A; Ambros PF; Gaze MN; McHugh K; Valteau-Couanet D; Ladenstein RL;
J Clin Oncol; 2020 Sep; 38(25):2902-2915. PubMed ID: 32639845
[TBL] [Abstract][Full Text] [Related]
6. The role of surgery in stage IV neuroblastoma.
Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A
J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542
[TBL] [Abstract][Full Text] [Related]
7. The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience.
McGregor LM; Rao BN; Davidoff AM; Billups CA; Hongeng S; Santana VM; Hill DA; Fuller C; Furman WL
Cancer; 2005 Dec; 104(12):2837-46. PubMed ID: 16288490
[TBL] [Abstract][Full Text] [Related]
8. Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma.
Chamberlain RS; Quinones R; Dinndorf P; Movassaghi N; Goodstein M; Newman K
Ann Surg Oncol; 1995 Mar; 2(2):93-100. PubMed ID: 7728576
[TBL] [Abstract][Full Text] [Related]
9. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
10. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
Kaneko M; Tsuchida Y; Mugishima H; Ohnuma N; Yamamoto K; Kawa K; Iwafuchi M; Sawada T; Suita S
J Pediatr Hematol Oncol; 2002 Nov; 24(8):613-21. PubMed ID: 12439032
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma in Turkish children: experience of a single center.
Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
[TBL] [Abstract][Full Text] [Related]
12. Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
Bagatell R; Beck-Popovic M; London WB; Zhang Y; Pearson AD; Matthay KK; Monclair T; Ambros PF; Cohn SL;
J Clin Oncol; 2009 Jan; 27(3):365-70. PubMed ID: 19047282
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.
Zobel M; Zamora A; Sura A; Wang L; Stein J; Marachelian A; Kim ES
J Surg Res; 2020 May; 249():8-12. PubMed ID: 31918331
[TBL] [Abstract][Full Text] [Related]
14. Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy.
Yanishevski D; McCarville MB; Doubrovin M; Spiegl HR; Zhao X; Lu Z; Federico SM; Furman WL; Murphy AJ; Davidoff AM
J Pediatr Surg; 2020 Jan; 55(1):130-134. PubMed ID: 31685267
[TBL] [Abstract][Full Text] [Related]
15. Survival from non-stage 4 neuroblastoma without cytotoxic therapy: an analysis of clinical and biological markers.
Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Ambros P; Ambros I; Ladanyi M; Eddy J; Bonilla MA; Gerald W
Eur J Cancer; 1997 Oct; 33(12):2117-20. PubMed ID: 9516865
[TBL] [Abstract][Full Text] [Related]
16. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
[TBL] [Abstract][Full Text] [Related]
17. Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt.
Elzomor H; Ahmed G; Elmenawi S; Elkinaai N; Refaat A; Soliman S; Abdelwahab MA; Zaghloul MS; Fawzy M
J Egypt Natl Canc Inst; 2018 Mar; 30(1):21-26. PubMed ID: 29428371
[TBL] [Abstract][Full Text] [Related]
18. Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma.
Koh CC; Sheu JC; Liang DC; Chen SH; Liu HC
Pediatr Surg Int; 2005 Feb; 21(2):69-72. PubMed ID: 15647910
[TBL] [Abstract][Full Text] [Related]
19. Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group.
Strother D; van Hoff J; Rao PV; Smith EI; Shamberger RC; Halperin EC; Murray KJ; Castleberry RP
Eur J Cancer; 1997 Oct; 33(12):2121-5. PubMed ID: 9516866
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
